TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2012

Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trial.

David P Carbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.